Skip to main content
PLOS One logoLink to PLOS One
. 2015 Feb 13;10(2):e0115050. doi: 10.1371/journal.pone.0115050

Associations among Sebox and Other MEGs and Its Effects on Early Embryogenesis

Min-Woo Park 1, Kyeoung-Hwa Kim 1, Eun-Young Kim 1, Su-Yeon Lee 1, Jung-Jae Ko 1,*, Kyung-Ah Lee 1,*
Editor: Qing-Yuan Sun2
PMCID: PMC4331730  PMID: 25679966

Abstract

In a previous report, we identified Sebox as a new candidate maternal effect gene that is essential for embryonic development and primarily impacts the two-cell (2C) stage. The present study was conducted to determine the mechanism of action for Sebox in this capacity, as shown by changes in the expression levels of other known MEG mRNAs after Sebox RNA interference (RNAi) in oocytes. Sebox-knockdown metaphase II (Mll) oocytes displayed normal morphology, but among the 23 MEGs monitored, 8 genes were upregulated, and 15 genes were unchanged. We hypothesized that the perturbed gene expression of these MEGs may cause the arrest of embryo development at the 2C stage and examined the expression of several marker genes for the degradation of maternal factors and zygotic genome activation. We found that some maternal mRNAs, c-mos, Gbx2, and Gdf9, were not fully degraded in Sebox-knockdown 2C embryos, and that several zygotic genome activation markers, Mt1a, Rpl23, Ube2a and Wee1, were not fully expressed in conjunction with diminished embryonic transcriptional activity. In addition, Sebox may be involved in the formation of the subcortical maternal complex through its regulation of the upstream regulator, Figla. Therefore, we concluded that Sebox is important in preparing oocytes for embryonic development by orchestrating the expression of other important MEGs.

Introduction

During fertilization, oocytes resume their meiotic division upon penetration by sperm. Thereafter, the initial cleavage of the zygote early in embryogenesis proceeds without differentiation and growth of the zygote until successful implantation in the mother’s uterus occurs. The particular events that occur during the journey from the oviduct to the uterus rely on factors that are encoded by maternal effect genes (MEGs), which accumulate over the course of oogenesis [1]. A milestone in early embryogenesis that is essential for further embryonic development is the maternal-to-zygotic transition (MZT) [2]. This is the point at which oocyte-specific maternal factors selectively disappear and male or female zygotic genomes are selectively activated. Zygotic genome activation (ZGA) in mice occurs at the two-cell (2C) to four-cell (4C) embryonic transition [3], whereas in bovine, ovine, and human species, this transition occurs at the 4C to eight-cell (8C) stage [4]. Thus, MZT abnormalities may culminate in embryonic arrest or lead to deficiencies in factors that are required for further developmental stages.

Growing oocytes synthesize and accumulate RNAs and proteins that contribute to the normal early embryonic development. Using annealing control primer PCR (described elsewhere), we previously detected differential gene expression levels in the germinal vesicle (GV) and metaphase II (MII) stages of oocyte maturation [5]. We also previously identified that Sebox expression was greater in GV than in MII oocytes and that Sebox plays a role as an MEG that is essential for embryonic development, functioning primarily at the 2C stage; however, the precise molecular mechanisms of Sebox as an MEG have yet to be clarified [6].

Recently, other sources have substantiated the importance of Sebox in early oogenesis [7]. Sebox is a mouse paired-like homeobox gene that encodes a transcription factor with a 60 amino acid single homeodomain motif (Fig. 1). In 2000, Cinquanta and colleagues reported the Sebox expression in skin, brain, oocytes, and 2-cell stage embryos [8]. Homeobox genes are a large class of transcriptional regulators that are essential for regulating cell differentiation and the formation of body structures during early embryonic development. Homeobox genes share a highly conserved DNA-binding domain of 60 amino acids, named the homeodomain, which binds to a specific DNA sequence and regulates expression of genes. Therefore, proteins that include a homeodomain play an essential role in both intracellular interactions and control of the expression of target genes.

Fig 1. Schematic diagram of the mouse Sebox mRNA (NM_008759.2) and protein (NP_032785.1).

Fig 1

SEBOX protein has a single homeodomain (black box) near the N-terminus and is considered to be a transcription factor. N, N-terminus; C, C-terminus.

MEGs were first described in Drosophila [9], but the concept of mammalian MEGs was first reported in 2000 [10], with the subsequent discovery of approximately 30 MEGs. MEGs are generally grouped by function during embryonic development as follows: 1) degradation of maternal factors, 2) chromatin remodeling, 3) transcriptional activity, 4) DNA methylation, 5) subcortical maternal complex (SCMC), and 6) pre-implantation development [11]. Therefore, due to their major role in embryogenesis, mutations of MEGs not only place embryonic development in jeopardy but may also compromise oocyte maturation and meiotic division. The present study was conducted to explore the role(s) of Sebox in early embryogenesis, assessing the influence of the loss-of-function of Sebox on the expression levels of other MEGs in oocytes and on early embryogenesis, particularly the degradation of maternal factors and the transcriptional activity of zygotes during MZT.

Materials and Methods

Research animals

ICR mice (female and male), exclusively provided by Koatech (Pyeoungtack, Korea), were mated to produce embryos in the breeding facility at the CHA Research Institute of CHA University. All procedures described herein were reviewed and approved by the Institutional Animal Care and Use Committee of CHA University and were performed in accordance with Guiding Principles for the Care and Use of Laboratory Animals.

Isolation of oocytes and embryos

Three-week-old female ICR mice were injected with 5 IU pregnant mare’s serum gonadotropin (PMSG; Sigma-Aldrich, St. Louis, MO, USA) and sacrificed 46 h later. Cumulus-enclosed oocyte complexes were then recovered from the ovaries by puncturing preovulatory follicles with 27-gauge needles. M2 medium (Sigma-Aldrich) containing 0.2 mM 3-isobutyl-1-methyl-xanthine (IBMX; Sigma-Aldrich) was used to inhibit germinal vesicle breakdown (GVBD). Cumulus cells were mechanically retrieved from oocytes by repeated extraction through a fine-bore pipette. Isolated murine oocytes were snap frozen and stored at -70°C prior to RNA isolation. Other female mice were superovulated and mated, and pronuclear embryos (PNs) were obtained 18–20 h after hCG injection.

Messenger RNA isolation

mRNA was isolated from oocytes and embryos at differing developmental stages using the Dynabeads mRNA DIRECT kit (Dynal Asa, Oslo, Norway) according to the manufacturer’s instructions. In short, oocytes were resuspended in 300 μl lysis/binding buffer (100 mM Tris-HCl [pH 7.5], 500 mM LiCl, 10 mM EDTA, 1% LiDS, and 5 mM dithiothreitol [DTT]) for 5 min at room temperature. After vortexing, 20 μl prewashed Dynabeads oligo dT25 was mixed with the lysate and annealed by rotating 5 min at room temperature. The beads were separated with a Dynal MPC-S magnetic particle concentrator, and poly(A)+ RNAs were eluted by incubation in 14 μl Tris-HCl (10 mM Tris-HCl, pH 7.5) at 73°C for 2 min.

Reverse-transcriptase polymerase chain reaction (RT-PCR)

Purified mRNA and 0.5 μg oligo (dT) primer were mixed and incubated at 70°C for 10 min, and cDNA was synthesized. Single oocyte- and single embryo-equivalent cDNAs were used as templates for PCR analysis. Primer sequences for the genes encoding Sebox, Figla and H1foo and PCR conditions are listed in Table 1. Thereafter, PCR products were separated by 1.5% agarose gel electrophoresis and analyzed using the Gel Doc EZ Imager (Bio-Rad). Relative gene expression levels were normalized to those of H1foo. All experiments were repeated three times.

Table 1. Primer sequences and Real-time RT-PCR conditions.

Gene Accession numbers Primer sequence* Annealing temperature Product size
Sebox-A NM_008759 F-AAAGCCAGGAGCCCTAAACT 60°C 334 bp
R-TTAGAAGTGGTCTACATTGG
Sebox-B NM_008759 F-GGAACATCAAGCCATCCTCT 60°C 293 bp
R-GGCCAGAGCCAAGACTTAAA
GFP KF111246.1 F-CTGAAGTTCATCTGCACCAC 60°C 334 bp
R-CGGCCATGATATAGACGTTG
H1foo NM_138311 F-AAGGAAGATGGCAGACATGG 60°C 137 bp
R-TCTTTGCCTTCCTGACCCTA
Actb NM_007393.3 F-GGGTGTGATGGTGGGAATGGG 60°C 489 bp
R-GCTGTGGTGGTGAAGCTGTAG
Gapdh BC092294 F-ACCACAGTCCATGCCATCAC 60°C 451 bp
R-TCCACCACCCTGTTGCTGTA
Ago2 NM_153178.4 F-AGAACATGACAGCGCTGAAG 60°C 115 bp
R-AAAGTACATGGTGCGCAGTG
Atg5 NM_053069.5 F-GCCTTTCATCCAGAAGCTG 60°C 149 bp
R-TTGGCTCTATCCCGTGAATC
Bmp15 NM_009757.4 F-TACAAGGTCAGCTTCCACCA 60°C 135 bp
R-ATGGCATGGTTGGGTGAA
Bnc1 NM_007562.2 F-ACCATCCTGGATTTGAGCAC 60°C 118 bp
R-TGCCATCACTGTCCTCCATA
Brg1 NM_001174078.1 F-CGGCAGAAGATTGAGAAGGA 60°C 119 bp
R-CCCAGCTTGATCTTCACCTT
Btg1 NM_007569 F-CGACAGCTGCAGACTTTCAG 60°C 238 bp
R-GGTAGGACACTTCGTAGGGG
Cdc2 NM_007659.3 F-GGACTACAAGAACACCTTTC 60°C 262 bp
R-CAGGAAGAGAGCCAACGGTA
c-mos NM_020021 F-TGGCTGTTCCTACTCATTTC 60°C 273 bp
R-CTTTATACACCGAGCCAAAC
Dicer1 NM_148948.2 F-AGTCTCTTGCTGGTGCCATT 60°C 148 bp
R-GGTTCCATCTCGAGCAATTC
Dnmt3a NM_007872.4 F-CCCTTCTTCTGGCTCTTTGA 60°C 117 bp
R-TGCAGCAGACACTTCTTTGG
Dnmt3l NM_019448.3 F-TGCTGACTGAGGATGACCAA 60°C 103 bp
R-ACCCGCATAGCATTCTGGTA
Eif1a NM_010120.5 F-ATGCTGGGAAATGGACGGTT 60°C 196 bp
R-AGGCCTTCAGACTTCTTGCT
Figla NM_012013.1 F-TGTTCTGGAAGAAGCGAAGG 60°C 117 bp
R-TGGGTAGCATTTCCCAAGAG
Filia NM_025890.3 F-ATGGAGAGCACATCCCACA 60°C 148 bp
R-TGAGCCAGATCAGTGAGCA
Floped NM_026480.3 F-ATCTTTGGACAACCCAGTGC 60°C 144 bp
R-TAGGATTGAGGAGGCACGAA
Gbx2 NM_010262.3 F-ATTTGCCTGGTCAGACTGCT 60°C 363 bp
R-TGCTAACGTGAACAGGGATG
Gdf9 NM_008110.2 F-TTGGCAGTCTCTTCAGTCCA 60°C 106 bp
R-GGGAGATCTTTCCACCTCAA
Hr6a NM_019668.3 F-CCAATAGTCCAGCAAACAGCC 60°C 100 bp
R-TCGCGCCAGCTTTGTTCTA
Hsf1 NM_008296.2 F-CAACAACATGGCTAGCTTCG 60°C 136 bp
R-CTGTCCACGCAAGAAACAAG
Hsp70.1 NM_010478.23 F-AACGTGCTCATCTTCGACCT 60°C 185 bp
R-TGGCTGATGTCCTTCTTGTG
Klf4 NM_010637 F-AAAAGAACAGCCACCCACAC 60°C 227 bp
R-GAAAAGGCCCTGTCACACTT
Kpna1 NM_008465.5 F-TCCAAGCAGTCATCGATGCA 60°C 250 bp
R-TGTGCCCTATTTCCAGCTGT
Mater NM_001039143.1 F-CCTTGGGAATGCCTTGAGTA 60°C 112 bp
R-GTTGCTGAAAAGGGCTGAGA
Mt1a NM_001039368.1 F-AAAATCTTTGTGGGCAGCCG 60°C 186 bp
R-TCTCTGCATCTGATGGGATC
Muerv-l Y12713 F-TTGCTTCCTGTCCCCATAAC 60°C 132 bp
R-AAAATGACCAGGGGGAAGTC
Nobox NM_130869.3 F-TTTCCCATCCCTTCAGTCAC 60°C 123 bp
R-TCTCCACTGAAGCCAAAAGG
Npm2 NM_181345.3 F-GAAAGCCAAAGAGGAGGTGA 60°C 146 bp
R-GCCGAAAAGTTACTGGAGGA
Oct4 NM_013633.3 F-CCGGAAGAGAAAGCGAACTA 60°C 112 bp
R-CTGATTGGCGATGTGAGTGA
Omt2b NM_205822.2 F-AGCAGACAGAAGGCAGCATT 60°C 215 bp
R-AGCAATAGTTCCGGCCTCAA
Padi6 NM_153106.2 F-TGGGAGGGAGAGCAAAACTA 60°C 129 bp
R-TTGTCCTCCAATCCCAGTTC
Rpl23 NM_022891.3 F-CATGGTGATGGCCACAGTTA 60°C 136 bp
R-GACCCCTGCGTTATCTTCAA
Stella NM_139218.1 F-TGTTGTCGGTGCTGAAAGAC 60°C 151 bp
R-CACTGTCCCGTTCAAACTCA
Tcl1 NM_009337.3 F-GAAGCTATGTCCCCCAGTCA 60°C 150 bp
R-TTCAAGCAACATGTCCTCCA
Tif1alpha NM_145076.3 F-ACCCAATGGACTTGTCAACC 60°C 148 bp
R-CCAGCATTGGCTACTTCAGA
Tle6 NM_053254.2 F-AACCTCAAAGGCCCTACCAA 60°C 134 bp
R-TGGAACAGATGCTCCAGTGA
Ube2a NM_019668.3 F-AATGGTTTGGAATGCGGTCA 60°C 272 bp
R-TGTTTGCTGGACTATTGGGA
U2afbp-rs NC_000077.6 F-TAAGCTGCAACCTGGAACCT 60°C 109 bp
R-CCTGCGTACCATCTTCCATT
Uchl1 NM_011670.2 F-GCCCAGCATGAAAACTTCAG 60°C 150 bp
R-CAGCTTGTCTTGGTTGTTGG
Wee1 NM_009516.3 F-AGCCATCTACCGAAAGCAGA 60°C 375 bp
R-ATCTGTGAAGAGTGCCCGTT
Zar1 NM_174877.3 F-GTTCTGCCGAGTGTGTGAGA 60°C 143 bp
R-CACACAAGTCTTGCCGATGG
Zfp57 NM_001013745.2 F-CAGCCATCCAGGACACCAG 60°C 144 bp
R-GCTTCCGACAAATGTCAGGTT
Zscan4 NR_033707.1 F-CAGATGCCAGTAGACACCAC 60°C 514 bp
R-GTAGATGTTCCTTGACTTGC

*F = Forward, R = Reverse

Quantitative real time RT-PCR

Quantitative real time RT-PCR analysis of embryonic MEG mRNA relied on the iCycler iQ Detection System (Bio-Rad Laboratories Inc, Hercules, CA, USA). iQ SYBR Green Supermix PCR reagents (Bio-Rad) were used to monitor amplification, and the results were analyzed using the iCycler iQ proprietary software. The reaction mixture contained cDNA, 20 pmol forward and reverse primers, and SYBR Green Supermix 2 (100 mM KCl, 40 mM Tris-HCl [pH 8.4], 0.4 mM each dNTP, 50 U/ml iTaq DNA polymerase, 6 mM MgCl2, SYBR Green I, 20 nM fluorescein, and stabilizers). The primer sequences used for the genes analyzed are listed in Table 1. Templates were amplified through 40 cycles of denaturation (40 sec, 95°C), annealing (40 sec, 60°C), and extension (40 sec, 72°C). Upon completion of PCR, fluorescence was monitored continuously as the samples were slowly heated from 60°C to 95°C at 0.5°C intervals. The melting curves were used to identify any nonspecific amplification products. The expression levels of each mRNA species in oocytes and embryos were normalized to those of H1foo and Actb, respectively. The relative expression levels of the target genes were evaluated using the comparative CT method [12, 13], and all analytic procedures were repeated at least three times.

Preparation of Sebox and GFP dsRNA

Sebox-A and GFP primers were used to amplify regions of Sebox and GFP cDNA, respectively, which were then cloned into pGEM-T Easy (Promega, Madison, WI, USA) and linearized with SpeI. A MEGAscript RNAi Kit (Ambion, Austin, TX, USA) and T7 RNA polymerase were used to synthesize single-stranded RNA (ssRNA) for each orientation. Complementary RNAs were mixed and incubated 5 min at 75°C and then cooled to room temperature. The formation of dsRNA was verified by 1% agarose gel electrophoresis, comparing the mobility of dsRNA with that of ssRNA. For microinjection, RNAs were diluted to a final concentration of 2 μg/μl. GFP RNAi was used as injection control.

Microinjection and in vitro culture

GV oocytes and PN embryos were microinjected with Sebox and GFP dsRNA in M2 medium containing 0.2 mM IBMX or in M2 medium alone, respectively. An injection pipette holding dsRNA solution was inserted into the cytoplasm of oocytes or embryos, and 10 pl dsRNA was microinjected with a constant-flow system (Femtojet; Eppendorf, Hamburg, Germany). To achieve the Mll stage, oocytes were cultured in M16 containing 0.2 mM IBMX for 8 h, followed by culture in plain M16 for 16 h in 5% CO2 at 37°C. Similarly, GFP and Sebox dsRNA-microinjected PN embryos were developed to the 2C stage in M16 medium containing 100 μM EDTA (Sigma-Aldrich).

Transcriptional activity assay

Newly synthesized RNAs, e.g., transcriptional activity, in embryos may be visualized by applying 5-ethynyl uridine (EU) to an in vitro embryonic transcriptional activity assay [12]. The Click-iT RNA Imaging Kit (Invitrogen, Carlsbad, CA, USA) was used for this purpose. After subjecting embryos to culture for 1 h in 2 mM EU-supplemented medium, embryos were washed three times for 10 min and fixed in 3.7% formaldehyde for 1 h. The preserved embryos were washed three times for 10 min and permeabilized by exposure to 0.2% Triton X-100 for 10 min. Finally, embryos were sequentially immersed in reaction buffer for 30 min, washed three times, and examined by confocal microscopy after the reaction buffer was eliminated with rinse buffer.

Statistical analysis

Statistical analysis of real time PCR data was carried out using student’s t-test. Data derived from at least three separate and independent experiments were expressed as the mean ± SEM. The p values were calculated based on a paired t-test of the triplicate delta CT values for each gene in the GFP RNAi group and Sebox RNAi group, and a value of p<0.05 was considered statistically significant.

Results

Expression levels of other MEGs impacted by Sebox RNAi

We previously reported the expression of Sebox mRNA in GV oocytes [6]. Knockdown of Sebox mRNA and protein in GV oocytes did not affect the meiotic cell cycle of oocytes, so the oocytes without Sebox expression developed to MII but were arrested at the 2C stage of early embryonic development. Although Sebox-knockdown GV oocytes developed to normal MII in appearance, the expression levels of the 8 among 23 studied MEGs were up-regulated (Fig. 2). These results suggest that Sebox is an important regulatory transcription factor that may function in controlling the expression of other MEGs during preimplantational embryonic development. In particular, 1 gene pertaining to degradation of maternal factors (Dicer), 4 genes related to DNA methylation (Dnmt3l, Dnmt1, Stella, and Zfp57), and 2 genes pertaining to SCMC organization (Mater, and Padi6) were up-regulated after Sebox RNAi knockdown (Fig. 2). The expression of Uchl1 related to preimplantation development was also up-regulated.

Fig 2. Altered expression of 23 MEGs in Sebox-knockdown Mll oocytes.

Fig 2

Quantitative real time RT-PCR experiments were repeated at least three times, expressing data as the mean±SEM. Expression levels were calculated from the CT values after normalization with H1foo. The statistical significance was assessed by a paired t-test with p values obtained by paired t-test within the delta CT values. Asterisks, *, **, and ***, represent statistical significance at p<0.0001, p<0.01 and p<0.05, respectively. Control, GFP dsRNA-injected MII oocyte; Sebox RNAi, Sebox dsRNA-injected MII oocyte.

Inadequate selective maternal mRNA degradation in Sebox knockdown 2C embryos

To determine the exact effects of the up-regulated expression levels of several MEGs on the 2C arrest after Sebox RNAi knockdown, particularly on the degradation of some maternal factors, we measured the degradation of several well-known maternal factors. Changes in expression of the maternal mRNAs Bmp15, c-mos, Gbx2, Gdf9, Nobox, and Omt2b were evident in 2C stage embryos after Sebox RNAi knockdown (Fig. 3). Compared with control 2C stage embryos, the expression levels of c-mos, Gbx2, and Gdf9 were relatively high in arrested 2C embryos after Sebox RNAi knockdown. The expression levels of the other known maternal factors, such as Nobox and Omt2b, were not changed. These results strongly suggest that Sebox is fairly involved in the process of degrading maternal factors.

Fig 3. Expression levels of selected maternal mRNAs in Sebox-knockdown 2C embryos.

Fig 3

To investigate the role of Sebox in degrading maternal mRNAs, Sebox RNAi knockdown PN embryos were developed to the 2C stage, and expression levels of maternal factors were determined by real time RT-PCR. Maternal factors that are typically absent in 2C control embryos, c-mos, Gbx2, Gdf9, were not degraded in Sebox-knockdown embryos arrested at the 2C stage (*p<0.05). The statistical significance was assessed by a paired t-test. Control, GFP dsRNA-injected 2C embryo; Sebox RNAi, Sebox dsRNA-injected 2C embryo.

Incomplete expression of ZGA markers after Sebox RNAi knockdown

Embryos subjected to Sebox RNAi knockdown were blocked at the 2C stage of embryonic development. Normal embryonic development requires ZGA, which should be indicated by expression of typical ZGA markers [13,14]. Thus, we determined the expression levels of known ZGA markers by comparing the 2C controls and 2C Sebox-knockdown zygotes (Fig. 4A-C). The expression levels of Btg1, Klf4, Kpna1, Muerv-1 were significantly up-retulated, while the expression of Mt1a, Rpl23, Ube2a and Wee1 were down-regulated after Sebox RNAi knockdown. Expression of Cdc2, Eif1a, Hsp70.1, U2afbp-rs and Zscan-4 were not significantly changed. These results demonstrate that Sebox is partly, but not exclusively, involved in ZGA.

Fig 4. Expression of zygotic genome activation (ZGA) markers in Sebox-knockdown 2C embryos.

Fig 4

To investigate the role of Sebox in ZGA, Sebox RNAi knockdown PN embryos were developed to the 2C stage, and the expression levels of 13 marker genes were determined by real time RT-PCR. The expression of 4 genes (Btg1, Klf4, Kpan1 and Muerv-l) were up-regulated (A), and 4 genes (Mt1a, Rpl23, Ube2a and Wee1) were down-regulated in Sebox-knockdown 2C embryos (B); while the expression levels of 5 genes (Cdc2, Eif1a, Hsp70.1, U2afbp-rs, and Zscan4) were unchanged. Asterisks, * and **, represent statistical significance at p<0.01 and p<0.05, respectively. Control, GFP dsRNA-injected 2C embryo; Sebox RNAi, Sebox dsRNA-injected 2C embryo.

Diminished transcriptional activity in Sebox knockdown 2C embryos

Due to the imperfect pattern of expression of several ZGA markers described above, we decided to evaluate the transcriptional activity of the 2C embryos by measuring EU incorporation in embryos with or without Sebox RNAi knockdown. Sebox-knockdown embryos showed dramatically decreased EU incorporation compared with control and sham-control embryos, confirming that the halted maternal factor degradation and ZGA during the MZT period caused by Sebox RNAi knockdown resulted in decreased transcription in embryos arrested at the 2C stage (Fig. 5).

Fig 5. Transcriptional activity assay of Sebox-knockdown 2C embryos.

Fig 5

Embryonic transcriptional activities were investigated by measuring embryonic nuclear EU incorporation. Control (A) and sham control (B) embryos showed normal levels of nuclear transcriptional activity, whereas transcriptional activity in Sebox-knockdown embryos (C) was diminished by comparison.

Expression of Figla in Sebox-knockdown Mll oocytes

Because 2 out of the 5 genes involved in SCMC formation, i.e., Mater, and Padi6, were up-regulated in Sebox-knockdown Mll oocytes, we evaluated changes in the known upstream regulators of SCMC. Figla, a germ-cell-specific, basic helix-loop-helix transcription factor, has been reported to be a key regulatory molecule in coordinating the expression of the NALP family of genes [15]. Three members of the NALP gene family have oocyte-specific expression [16]. Among them, Nalp5 (also known as Mater) is important in the formation of the SCMC complex [17]. Thus, we evaluated the expression levels of Figla after Sebox RNAi knockdown and found that expression levels increased 11.7-fold in Sebox-knockdown Mll oocytes compared with the controls (Fig. 6). Consequently, we concluded that Sebox, either directly and/or indirectly through Figla, regulates the expression of SCMC component genes.

Fig 6. Expression of Figla in Sebox-knockdown Mll oocytes.

Fig 6

Up-regulated expression of Figla, a known upstream regulator of SCMC, was confirmed in Sebox-knockdown Mll oocytes. Control, GFP dsRNA-injected MII oocyte; Sebox RNAi, Sebox dsRNA-injected MII oocyte.

Discussion

During the MZT, gene expression is dramatically altered as a necessary step in embryonic development. By definition, MEGs are transcribed during oogenesis and are required for early developmental activities, such as establishing the overall polarity of the embryo. Some MEGs are expressed only in female gametes, whereas others are expressed after the embryonic genome is activated [18]. The timing of embryonic gene activation is species-specific [19]. In mice, embryonic gene activation occurs at the 2C stage, concurrently with the degradation of most maternal mRNA transcripts [20]. Global expression profiles have identified distinctive patterns of maternal mRNA degradation and zygotic genome activation in mice, indicating remarkably dynamic reprogramming of gene expression at the 2C stage [2123].

One major point of inquiry was whether developmental repercussion is found in Sebox-knockdown 2C embryos. In this study, Sebox-deficient MII oocytes displayed altered expression of several MEGs. First, the role of Sebox in degrading maternal factors was investigated. The degradation of maternal factors is initiated during oocyte maturation and proceeds after fertilization [24]. To support early embryogenesis, the degradation of previously existing factors is a crucial and selective process [25]. We measured the expression of known maternal mRNAs (Bmp15, c-mos, Gbx2, Gdf9, Nobox, and Omt2b), all of which should be degraded in normal 2C zygotes, and found incomplete elimination of c-mos, Gbx2, and Gdf9 after Sebox RNAi knockdown. Such abnormal clearance of maternal factors likely translates to latent defects in embryonic development.

Next, we confirmed the presence of abnormal ZGA and found that Mt1a, Rpl23, Ube2a and Wee1 were down-regulated after Sebox RNAi knockdown but that Cdc2, Eif1a, Hsp70.1, U2afbp-rs, and Zscan4 were not. Furthermore, expression of 4 more genes, Btg1, Klf4, Kpna1, and Muerv-1 were even up-regulated after the loss of Sebox. This finding suggests that Sebox is certainly a significant regulator of ZGA, but it is not critical or exclusive because the expression levels of 5 out of 13 genes were not affected. SEBOX contains a homeodomain and may thus act as a transcription factor [8,26,27]. Indeed, a transcriptional activity assay confirmed a reduction of embryonic transcriptional activity after Sebox RNAi knockdown. Therefore, the regulation of ZGA by SEBOX and its control over the expression of other MEGs may occur at the transcriptional level. Further research on the interrelationship between SEBOX as a transcriptional factor and promoters of altered MEG expression levels is required.

An interesting outcome of this study was the finding that the expression levels of SCMC components were increased after Sebox RNAi knockdown. The SCMC encompasses many maternal proteins, of which FILIA, FLOPED, MATER, PADI6, and TLE6 are crucial for progression beyond the first embryonic cell division [17]. Among these components, FLOPED, MATER, and TLE6 proteins show interactivity, whereas Filia and MATER bind directly in embryos [28]. According to previous findings, Figla is a key regulatory molecule of Nalp5, also known as Mater [16], and MATER has an important role in SCMC complex formation [17,28]. We confirmed a relationship between Sebox and Figla and found it noteworthy that Sebox depletion up-regulated Figla expression. These findings strongly suggest that Sebox, Figla, and SCMC components are linked. The specific interrelationships of MEGs have not been fully elucidated. Our results may provide a greater impetus to probe such relationships, exploring the direct/indirect interplay among SEBOX, FIGLA, and other MEGs, at both the transcriptional and post-translational levels.

Other publications have stressed the importance of the MZT in early embryonic development [2931]. Arrest of α-amanitin-treated embryos at the 1C or 2C stage has been documented [32], and developmental block at the 2C stage has been attributed to delayed ZGA [33]. However, the specific molecular mechanism of the MZT in mice is still unclear. We believe that SEBOX is an important regulator of the MZT in addition to the genes that have been discovered to be active during the MZT [34].

Aside from their impact on embryonic development, a variety of functions have been ascribed to many MEGs in oocytes. Basonuclin-deficient oocytes containing cytoplasmic granules have been found to arrest at the 2C stage [35]; Ctcf-deficient oocytes showed delayed GVBD and embryonic developmental arrest [36]; and Padi6 is thought to regulate microtubular and organelle dynamics during oocyte maturation and to contribute to the SCMC during early embryogenesis [37]. We previously reported that Gas6 contributes to the cytoplasmic maturation of oocytes and PN formation [38]. Additionally, in the present study, we report that even though Sebox-knockdown oocytes developed to the MII stage with normal morphology, Sebox knockdown may contribute to the incompetent cytoplasmic maturation of oocytes, which affects early embryo development.

In conclusion, our findings support an intimate association between Sebox and other MEGs, whereby Sebox is involved in regulating the elimination of maternal factors and promotion of embryonic gene expression required for normal developmental progression. These perturbed cytoplasmic expression levels that we observed for various genes in Sebox-deficient mouse oocytes signify impaired fertilization and embryonic development and thus merit further investigation.

Acknowledgments

The authors are very grateful to Professor Jisook Moon, Department of Bioengineering, CHA University for her technical assistance in statistical analysis.

Data Availability

All relevant data are within the paper.

Funding Statement

This work was supported by the Priority Research Centers Program, through the National Research Foundation of Korea (NRF), and funded by the Ministry of Education, Science, and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Latham KE (1999) Mechanisms and control of embryonic genome activation in mammalian embryos. Int Rev Cytol 193: 71–124. [DOI] [PubMed] [Google Scholar]
  • 2. Schultz RM (2002) The molecular foundations of the maternal to zygotic transition in the preimplantation embryo. Hum Reprod Update 8: 323–331. [DOI] [PubMed] [Google Scholar]
  • 3. Wang H, Dey SK (2006) Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 7: 185–199. [DOI] [PubMed] [Google Scholar]
  • 4. Telford NA, Watson AJ, Schultz GA (1990) Transition from maternal to embryonic control in early mammalian development: a comparison of several species. Mol Reprod Dev 26: 90–100. [DOI] [PubMed] [Google Scholar]
  • 5. Yoon SJ, Chung HM, Cha KY, Kim NH, Lee KA (2005) Identification of differential gene expression in germinal vesicle vs. metaphase II mouse oocytes by using annealing control primers. Fertil Steril 83 Suppl 1: 1293–1296. [DOI] [PubMed] [Google Scholar]
  • 6. Kim KH, Kim EY, Lee KA (2008) SEBOX is essential for early embryogenesis at the two-cell stage in the mouse. Biol Reprod 79: 1192–1201. 10.1095/biolreprod.108.068478 [DOI] [PubMed] [Google Scholar]
  • 7. Moreno DL, Salazar Z, Betancourt M, Casas E, Ducolomb Y, et al. (2014) Sebox plays an important role during the early mouse oogenesis in vitro. Zygote 22: 64–68. 10.1017/S0967199412000342 [DOI] [PubMed] [Google Scholar]
  • 8. Cinquanta M, Rovescalli AC, Kozak CA, Nirenberg M (2000) Mouse Sebox homeobox gene expression in skin, brain, oocytes, and two-cell embryos. Proc Natl Acad Sci U S A 97: 8904–8909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Nusslein-Volhard C, Lohs-Schardin M, Sander K, Cremer C (1980) A dorso-ventral shift of embryonic primordia in a new maternal-effect mutant of Drosophila. Nature 283: 474–476. [DOI] [PubMed] [Google Scholar]
  • 10. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, et al. (2000) Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet 26: 267–268. [DOI] [PubMed] [Google Scholar]
  • 11. Li L, Zheng P, Dean J (2010) Maternal control of early mouse development. Development 137: 859–870. 10.1242/dev.039487 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Waksmundzka M, Debey P (2001) Electric field-mediated BrUTP uptake by mouse oocytes, eggs, and embryos. Mol Reprod Dev 58: 173–179. [DOI] [PubMed] [Google Scholar]
  • 13. Zeng F, Schultz RM (2005) RNA transcript profiling during zygotic gene activation in the preimplantation mouse embryo. Dev Biol 283: 40–57. [DOI] [PubMed] [Google Scholar]
  • 14. Kigami D, Minami N, Takayama H, Imai H (2003) MuERV-L is one of the earliest transcribed genes in mouse one-cell embryos. Biol Reprod 68: 651–654. [DOI] [PubMed] [Google Scholar]
  • 15. Joshi S, Davies H, Sims LP, Levy SE, Dean J (2007) Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor. BMC Dev Biol 7: 67 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Hamatani T, Falco G, Carter MG, Akutsu H, Stagg CA, et al. (2004) Age-associated alteration of gene expression patterns in mouse oocytes. Hum Mol Genet 13: 2263–2278. [DOI] [PubMed] [Google Scholar]
  • 17. Li L, Baibakov B, Dean J (2008) A subcortical maternal complex essential for preimplantation mouse embryogenesis. Dev Cell 15: 416–425. 10.1016/j.devcel.2008.07.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Kim KH, Lee KA (2014) Maternal effect genes: Findings and effects on mouse embryo development. Clin Exp Reprod Med 41: 47–61. 10.5653/cerm.2014.41.2.47 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Zernicka-Goetz M (1994) Activation of embryonic genes during preimplantation rat development. Mol Reprod Dev 38: 30–35. [DOI] [PubMed] [Google Scholar]
  • 20. Schultz RM (1993) Regulation of zygotic gene activation in the mouse. Bioessays 15: 531–538. [DOI] [PubMed] [Google Scholar]
  • 21. Zeng F, Baldwin DA, Schultz RM (2004) Transcript profiling during preimplantation mouse development. Dev Biol 272: 483–496. [DOI] [PubMed] [Google Scholar]
  • 22. Hamatani T, Carter MG, Sharov AA, Ko MS (2004) Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell 6: 117–131. [DOI] [PubMed] [Google Scholar]
  • 23. Wang QT, Piotrowska K, Ciemerych MA, Milenkovic L, Scott MP, et al. (2004) A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo. Dev Cell 6: 133–144. [DOI] [PubMed] [Google Scholar]
  • 24. Paynton BV, Rempel R, Bachvarova R (1988) Changes in state of adenylation and time course of degradation of maternal mRNAs during oocyte maturation and early embryonic development in the mouse. Dev Biol 129: 304–314. [DOI] [PubMed] [Google Scholar]
  • 25. Alizadeh Z, Kageyama S, Aoki F (2005) Degradation of maternal mRNA in mouse embryos: selective degradation of specific mRNAs after fertilization. Mol Reprod Dev 72: 281–290. [DOI] [PubMed] [Google Scholar]
  • 26. Lee HS, Kim EY, Lee KA (2011) Changes in gene expression associated with oocyte meiosis after Obox4 RNAi. Clin Exp Reprod Med 38: 68–74. 10.5653/cerm.2011.38.2.68 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Park GT, Lee KA (2013) Nuclear localization of Obox4 is dependent on its homeobox domain. Clin Exp Reprod Med 40: 1–6. 10.5653/cerm.2013.40.1.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ohsugi M, Zheng P, Baibakov B, Li L, Dean J (2008) Maternally derived FILIA-MATER complex localizes asymmetrically in cleavage-stage mouse embryos. Development 135: 259–269. [DOI] [PubMed] [Google Scholar]
  • 29. Tadros W, Lipshitz HD (2009) The maternal-to-zygotic transition: a play in two acts. Development 136: 3033–3042. 10.1242/dev.033183 [DOI] [PubMed] [Google Scholar]
  • 30. Tsai TC, Lin W, Yang SH, Cheng WT, Cheng EH, et al. (2010) Granzyme G is expressed in the two-cell stage mouse embryo and is required for the maternal-zygotic transition. BMC Dev Biol 10: 88 10.1186/1471-213X-10-88 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Rother F, Shmidt T, Popova E, Krivokharchenko A, Hugel S, et al. (2011) Importin alpha7 is essential for zygotic genome activation and early mouse development. PLoS One 6: e18310 10.1371/journal.pone.0018310 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Golbus MS, Calarco PG, Epstein CJ (1973) The effects of inhibitors of RNA synthesis (alpha-amanitin and actinomycin D) on preimplantation mouse embryogenesis. J Exp Zool 186: 207–216. [DOI] [PubMed] [Google Scholar]
  • 33. Qiu JJ, Zhang WW, Wu ZL, Wang YH, Qian M, et al. (2003) Delay of ZGA initiation occurred in 2-cell blocked mouse embryos. Cell Res 13: 179–185. [DOI] [PubMed] [Google Scholar]
  • 34. Lykke-Andersen K, Gilchrist MJ, Grabarek JB, Das P, Miska E, et al. (2008) Maternal Argonaute 2 is essential for early mouse development at the maternal-zygotic transition. Mol Biol Cell 19: 4383–4392. 10.1091/mbc.E08-02-0219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Ma J, Zeng F, Schultz RM, Tseng H (2006) Basonuclin: a novel mammalian maternal-effect gene. Development 133: 2053–2062. [DOI] [PubMed] [Google Scholar]
  • 36. Wan LB, Pan H, Hannenhalli S, Cheng Y, Ma J, et al. (2008) Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development. Development 135: 2729–2738. 10.1242/dev.024539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Yurttas P, Vitale AM, Fitzhenry RJ, Cohen-Gould L, Wu W, et al. (2008) Role for PADI6 and the cytoplasmic lattices in ribosomal storage in oocytes and translational control in the early mouse embryo. Development 135: 2627–2636. 10.1242/dev.016329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Kim KH, Kim EY, Kim Y, Kim E, Lee HS, et al. (2011) Gas6 downregulation impaired cytoplasmic maturation and pronuclear formation independent to the MPF activity. PLoS One 6: e23304 10.1371/journal.pone.0023304 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES